In summary, serum HMGB1 may reflect the regulatory response of the inflammatory state during DKD pathogenesis, and can be used as a potential marker for the prediction of DKD, which is helpful for the diagnosis and targeted treatment of DKD. This evidence concerns the gene HMGB1 and diabetic kidney disease.